Overview

Brain Imaging and Mental Disorders of Aging Intervention

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to determine if a cholinesterase inhibitor is more effective than placebo in delaying cognitive and brain functional decline in people at risk for Alzheimer's disease.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Aging (NIA)
Treatments:
Donepezil